Johnson & Johnson has been in a holding pattern, posting a small return of 0.7% while floating around $163.19.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Johnson & Johnson (JNJ – Research ...

Executives mingled with North Carolina leaders in the city of Wilson to ceremonially break ground on Johnson & Johnson’s ...

According to an announcement by the pharmaceutical company, Johnson & Johnson (JNJ) will invest over $55 billion in various ...

In a report released yesterday, Vamil Divan from Guggenheim reiterated a Buy rating on Eledon Pharmaceuticals (ELDN – Research Report), with a ...

In appraisal of Kenvue’s visual identity, the logo for the independent new company is said to represent Johnson & Johnson’s timelessness, while “allowing space for its iconic brands to have ...

it wasn't until 1959 – 73 years and two major acquisitions later – that J&J developed its significant presence in the pharmaceutical industry. In 1886, three brothers – Robert Wood Johnson ...

The US Vaccines Market, (excluding COVID-19 vaccines), valued at US$25.98 billion in 2024, is forecasted to grow at a robust ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

NICE and Deloitte Digital today announced an alliance developed to transform customer service by offering end-to-end AI and service automation. This collaboration is geared towards making customer ...